Overcoming Silos to Address Infection-Related Global Health Threats (Session 3 – 4th WSC)
Session 3 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:

00:00 Intro
00:34 Brenda Morrow – Introduction
01:43 Jyoti Joshi – Breaking the Silos, Stopping the Spread
07:41 Mike English – Newborn and Child Health in Low- and Middle-Income Countries Is Critically Dependent Upon Cross-Sector Working
11:47 Ximena Garzón-Villalba – Working in Silos Does Not Work for Outbreak Responses
17:42 Catherine Machalaba – Breaking the Silos – Improving Global Health Through Cross-Sectoral Action
22:40 Shevin Jacob – Why Silos Are Killing People in Low- and Middle-Income Countries
28:44 Panel Discussion

All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518

Session 4 will be available momentarily. Sessions 5 and 6 will follow on May 16, 2023. The full release schedule is available at https://www.worldsepsiscongress.org/watch

Thanks for watching and sharing.

The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.

Stop Sepsis – Save Lives

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.